Key facts
- This page summarizes Bryan T. Vaughn's Form 4 filing for LABCORP HOLDINGS INC. (LH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2026, 15:42.
Bryan T. Vaughn - 10 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)
- Reporting relationship
- EVP, Diagnostics
- Issuer ticker
- LH
- Reported as of
- 10 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2026, 15:42:51 UTC
- Prior SEC filing
- 10 Feb 2026
- Next SEC filing
- 13 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bryan T. Vaughn filed Form 4 for LABCORP HOLDINGS INC. (LH) on 12 Feb 2026.
Change
- Previous filing in this sequence was filed on 10 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002103999
Primary reporting owner
Vaughn Bryan T
- Relationship
- EVP, Diagnostics
- Address
- 531 SOUTH SPRING STREET, BURLINGTON
- Signature
- /s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn
- Signature date
- 12 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Non-qualified Stock Options
Award
- Transaction value
- $0
- Shares
- +2,200
- Change %
- Price
- $0.000000
- Shares after
- 2,200
- Date
- 10 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,200
- Exercise price
- $284.50
- Footnotes
- F1, F2
LH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +730
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 4,354
- Date
- 10 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 730
- Exercise price
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
Footnote F2
The option vests in three equal annual installments beginning on the date reflected in this column.
Footnote F3
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Footnote F4
The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
Footnote F5
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.